National registration survey of superficial head and neck cancer

National registration survey of superficial head and neck cancer - National registration survey of superficial head and neck cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000008276

Enrollment

250

Registered

2012-06-27

Start date

2012-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

head and neck cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Histologically confirmed squamous-cell carcinoma (including high-grade intraepithelial neoplasia) 2. Histologically confirmed superficial head and neck cancer 3. Transoral resection was performed by December 2009 (irrespective of the presence or absence of additional treatment) 4. A tumor-negative vertical margin of the resected specimen 5. Lesions localized to the oropharynx/hypopharynx or supraglottis (including lesions partially involving the cervical esophagus) 6. No clinical evidence of lymph-node metastasis 7. The absence of active advanced head and neck cancer (patients with metachronous multiple cancer after surgery or chemoradiotherapy can be enrolled)

Exclusion criteria

Exclusion criteria: Patients judged by their attending physician to be unsuitable for enrollment

Design outcomes

Primary

Measure	Time frame
1. Survey of clinical and histopathological characteristics of superficial head and neck cancer 2. Survey of outcomes including overall survival, disease-free survival, relapse-free survival, metastatic relapse-free survival, and cause-specific survival 3. Rates of local failure and recurrence 4. Rates of lymph-node and distant metastases 5. Incidence of metachronous cancer 6. Incidence of second primary cancer 7. Evaluation of risk factors for local failure, relapse, and metastatic relapse 8. Survey of adverse events associated with treatment 9. Rate of organ preservation	—

Measure

Time frame

1. Survey of clinical and histopathological characteristics of superficial head and neck cancer 2. Survey of outcomes including overall survival, disease-free survival, relapse-free survival, metastatic relapse-free survival, and cause-specific survival 3. Rates of local failure and recurrence 4. Rates of lymph-node and distant metastases 5. Incidence of metachronous cancer 6. Incidence of second primary cancer 7. Evaluation of risk factors for local failure, relapse, and metastatic relapse 8. Survey of adverse events associated with treatment 9. Rate of organ preservation

—

Countries

Japan

Contacts

Public ContactChikatoshi Katada

Kitasato University School of Medicine Department of Gastroenterology

Outcome results